Kaitlyn D’Onofrio

DocwireNews

Increasing <a href="https://proddocwire.wpengine.com/docwire-pick/home-page-picks/exercise-diabetes-cardiovascular-disease/">physical activity</a> may be more beneficial than pharmacological intervention in lowering visceral fat, according to recent research.&ldquo;Visceral fat can affect local organs or the entire body system,&rdquo; said Dr. Ian J. Neeland, senior study author and an assistant professor of internal medicine, in a <a href="https://www.eurekalert.org/pub_releases/2019-02/usmc-tdo013119.php">press release</a>. &ldquo;Systemically it can affect your heart and liver, as well as abdominal organs. When studies use weight or body mass index as a metric, we don&rsquo;t know if the interventions are reducing fat everywhere in the body, or just near the surface.&rdquo;<a href="https://www.diabetes.co.uk/body/visceral-fat.html">Visceral fat</a> is associated with numerous diseases, including type 2 diabetes, heart disease, breast and colorectal cancers, and Alzheimer&rsquo;s disease.The review, published in the February issue of Mayo Clinic Proceedings, included randomized, controlled trials that compared monitored exercise to pharmacological interventions in how effectively they reduced visceral adipose tissue (VAT). Queried databases included Ovid MEDLINE, Scopus, Web of Science, Cochrane Library, ClinicalTrials.gov, New York Academy of Science Grey Literature Report, and OpenGrey, in addition to hand searches of existing literature.After evaluating 2,515 titles and abstracts, researchers narrowed it down to 17 for the final analysis, including a total of 3,602 patients (mean age, 54 years; 65% female; mean body mass index at enrollment, 31 mg/k2). Although pharmacological interventions were beneficial in reducing VAT, exercise proved to be more effective (pharmacological interventions: standardized mean difference [SMD], &minus;0.54; 95% CI, &minus;0.63 to &minus;0.46; P &lt;.001 vs. exercise interventions: (SMD, &minus;0.54; 95% CI, &minus;0.63 to &minus;0.46; P &lt; .001).&ldquo;<a href="https://proddocwire.wpengine.com/abstracts/chronic-obstructive-pulmonary-disease-trial/">Exercise interventions</a> resulted in greater reduction in VAT relative to weight loss than did pharmacological interventions,&rdquo; the researchers wrote in their abstract. &ldquo;A preferential reduction in VAT may be clinically meaningful when monitoring success of interventions because weight loss alone may underestimate benefits.&rdquo;<a href="https://proddocwire.wpengine.com/abstracts/exercise-mortality-childhood-cancer/">Association of Exercise With Mortality in Adult Survivors of Childhood Cancer</a><a href="https://proddocwire.wpengine.com/abstracts/rheumatology-abstracts/nonspecific-low-back-pain/">Effect of 12-Week Whole-Body Vibration Exercise on Lumbopelvic Proprioception and Pain Control in Young Adults with Nonspecific Low Back Pain</a>Source: <a href="https://www.mayoclinicproceedings.org/article/S0025-6196(18)30854-1/fulltext">Mayo Clinic Proceedings</a>

Bradley Marder, MD

Joel M. Topf, MD, FACP

Gout Studies: Transplant Waitlisting and Bone Erosion

NKF Spring Clinical Meetings 2025

Jayme Locke, MD, MPH

The Promise of Xenotransplantation

Leah Lawrence

Real-World Data Backs Invasive DFS as Surrogate Endpoint for OS in EBC

HR Breast Cancer

Latest News

Best Approach to Reduce Visceral Fat Is Exercise

Cardiology

Increasing physical activity may be more beneficial than pharmacological intervention in lowering visceral fat, according to recent research. ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe